(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS's recent 2 invited interviews from domestic economic magazines following Series B financing

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-11-06 11:40
  • 조회 : 62회

본문

 

15 Oct 2020

5 Nov 2020

 

ILIAS's recent 2 invited interviews from domestic economic magazines following Series B financing.

Sincere thanks to Sedaily, and The Korea Economic Daily for inviting ILIAS Biologics to an interview after the recent Series B financing round.

Sedaily spotlights ILIAS as one of the top companies in the SEOUL BIOHUB, a support hub for biomedical startup companies.

The Korea Economic Daily pays attention to ILIAS's business plan following recent fundraising, the motivation for company foundation, the potential of exosomes as therapeutics, EXPLOR® platform technology, clinical development plan.

 

Please find the link below for more information. 

Press from Sedaily (Kor)

Press from The Korea Economic Daily (Kor)

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기